The online version of this article (https://doi.org/10.1007/s11764-018-0717-5) contains supplementary material, which is available to authorized users.
Nancy L. Keating & Clare R. Bankhead are co-senior authors.
Overlooking other medical conditions during cancer treatment and follow-up could result in excess morbidity and mortality, thereby undermining gains associated with early detection and improved treatment of cancer. We compared the quality of care for diabetes patients subsequently diagnosed with breast, colorectal, or prostate cancer to matched, diabetic non-cancer controls.
Longitudinal cohort study using primary care records from the Clinical Practice Research Datalink, United Kingdom. Patients with pre-existing diabetes were followed for up to 5 years after cancer diagnosis, or after an assigned index date (non-cancer controls). Quality of diabetes care was estimated based on Quality and Outcomes Framework indicators. Mixed effects logistic regression analyses were used to compare the unadjusted and adjusted odds of meeting quality measures between cancer patients and controls, overall and stratified by type of cancer.
3382 cancer patients and 11,135 controls contributed 44,507 person-years of follow-up. In adjusted analyses, cancer patients were less likely to meet five of 14 quality measures, including: total cholesterol ≤ 5 mmol/L (odds ratio [OR] = 0.82; 95% confidence interval [CI], 0.75–0.90); glycosylated hemoglobin ≤ 59 mmol/mol (adjusted OR = 0.77; 95% CI, 0.70–0.85); and albumin creatinine ratio testing (adjusted OR = 0.83; 95% CI, 0.75–0.91). However, cancer patients were as likely as their matched controls to meet quality measures for other diabetes services, including retinal screening, foot examination, and dietary review.
Although in the short-term, cancer patients were less likely to achieve target thresholds for cholesterol and HbA1c, they continued to receive high-quality diabetes primary care throughout 5 years post diagnosis.
These findings are important for cancer survivors with pre-existing diabetes because they indicate that high-quality diabetes care is maintained throughout the continuum of cancer diagnosis, treatment, and follow-up.
Cancer Research UK. Cancer survival for common cancers. Available from: http://health-pr.com/health-professional/cancer-statistics/survival/common-cancers-compared#undefined (accessed 11 January 2017).
Ning Y, Shen Q, Herrick K, et al. Cause of death in cancer survivors. Cancer Res. 2012;72(8 Suppl):Abstract nr LB-339.
Cancer Research UK. Longer cancer survival means nearly half of cancer patients die from other diseases. Available from: http://www.cancerresearchukorg/about-us/cancer-news/news-report/2012-04-03-longer-cancer-survival-means-nearly-half-of-cancer-patients-die-from-other-diseases?view=rss (accessed 11 January 2017).
Macmillan Cancer Support. Throwing light on the consequences of cancer and its treatment July 2013. Available from: http://wwwncsiorguk/wp-content/uploads/MAC14312_CoT_Throwing-light_report_FINALpdf (accessed 1 February 2016).
Giovannuci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674–85. CrossRef
Keating NL, O’Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol. 2006;24(27):4448–56. CrossRef
Barone BB, Yeh H-C, Snyder CF, Peairs KS, Stein KB, Derr RL, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300(23):2754–64. CrossRef
Snyder CF, Frick KD, Herbert RJ, Blackford AL, Neville BA, Wolff AC, et al. Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. J Clin Oncol. 2013;31(9):1140–8. CrossRef
Irizarry L, Li QE, Duncan I, Thurston AL, Fitzner KA, Edwards BJ, et al. Effects of cancer comorbidity on disease management: making the case for diabetes education (a report from the SOAR program). Popul Health Manag. 2013;16(1):53–7. CrossRef
Bayliss EA, Blatchford PJ, Newcomer SR, Steiner JF, Fairclough DL. The effect of incident cancer depression and pulmonary disease exacerbations on type 2 diabetes control. J Gen Intern Med. 2011;26(6):575–81. CrossRef
Chiao EY, Nambi PV, Naik AD. The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer. J Cancer Surviv. 2010;4(4):381–7. CrossRef
Hanchate AD, Clough-Gorr KM, Ash AS, Thwin SS, Silliman RA. Longitudinal patterns in survival comorbidity healthcare utilization and quality of care among older women following breast cancer diagnosis. J Gen Intern Med. 2010;25(10):1045–50. CrossRef
Keating NL, Zaslavsky AM, Herrinton LJ, Selby JV, Wolf RE, Ayanian JZ. Quality of diabetes care among cancer survivors with diabetes. Med Care. 2007;45(9):869–75. CrossRef
Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer. 2004;101(8):1712–9. CrossRef
Khan NF, Mant D, Rose PW. Quality of care for chronic diseases in a British cohort of long-term cancer survivors. Ann Fam Med. 2010;8(5):418–24. CrossRef
Clinical Practice Research Datalink. Available from: https://wwwcprdcom/introasp (accessed 11 January 2017).
Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827–36. CrossRef
Primary Care Commissioning. Available from: http://wwwpcc-cicorguk/article/qof-business-rules-v250 (accessed 11 January 2017).
Rosenbaum PR. Observational studies. 2nd ed. New York: Springer-Verlang; 2002. CrossRef
Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516–24. CrossRef
Guo S, Fraser MW. Propensity score analysis: statistical methods and applications advanced quantitative techniques in the social sciences 12. Los Angeles: Sage Publications Inc.; 2010.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. CrossRef
Khan NF, Perera R, Harper S, Rose PW. Adaptation and validation of the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract. 2010;11:1. CrossRef
Kontopantelis E, Springate DA, Reeves D, Ashcroft DM, Rutter M, Buchan I, et al. Glucose blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study. Diabetologia. 2015;58(3):505–18. CrossRef
Dave S, Petersen I. Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf. 2009;18(8):704–7. CrossRef
Marston L, Carpenter JR, Walters KR, Morris RW, Nazareth I, Petersen I. Issues in multiple imputation of missing data for large general practice clinical databases. Pharmacoepidemiol Drug Saf. 2010;19:618–26. CrossRef
Thissen D, Steinberg L, Kuang D. Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons. J Educ Behav Stat. 2002;27(1):77–83. CrossRef
Samuel CA, Landrum MB, McNeil BJ, Bozeman SR, Williams CD, Keating NL. Racial disparities in cancer care in the veterans affairs health care system and the role of site of care. Am J Public Health. 2014;104(Suppl 4):S562–71. CrossRef
Williams VSL, Jones LV, Tukey JW. Controlling error in multiple comparisons with examples from state-to-state differences in educational achievement. J Educ Behav Stat. 1999;24(1):42–69. CrossRef
StataCorp. Stata statistical software: release 14. College Station: StataCorp LP; 2015.
Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using Stata; volume II: categorcial responses counts and survival. 3rd ed. College Station: StataCorp LP; 2012.
Boggon R, van Staa TP, Chapman M, Gallagher AM, Hammad TA, Richards MA. Cancer recording and mortality in the general practice research database and linked cancer registries. Pharmacoepidemiol Drug Saf. 2013;22:168–75. CrossRef
- Quality of diabetes care in breast, colorectal, and prostate cancer
Robert I. Griffiths
Emily C. McFadden
Richard J. Stevens
Jose M. Valderas
Bernadette A. Lavery
Nada F. Khan
Nancy L. Keating
Clare R. Bankhead
- Springer US